Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: Complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 176-183

  Malbrain, Manu L N G ^a,b   Van Den Bergh, Herman ^a   Zachée, Pierre ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Stuivenberg General Hospital   (Belgium)

Author keywords

Chromosomal abnormality; Cytogenetic remission; HES; Idiopathic hypereosinophilic syndrome; Interferon alpha

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA; METHYLPREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CASE REPORT; CELL CLONE; CHROMOSOME ABERRATION; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; MALE; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 9; HEMATOPOIETIC STEM CELLS; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERFERON ALFA-2B; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 0030030224     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.00298.x     Document Type: Article

References (55)

1. Baumgarten, E., Wegner, R.D., Fengler, R., Ludwig, W.D., Schulte-Overberg, U., Domeyer, C. Schuurman, J. & Henze, G. (1989) CALLA-positive acute leukaemia with t(5q;14q) translocation and hypereosinophilia: a unique entity? Acta Haematologica, 82, 85-90.
2. Bitran, J.D., Rowley, J.D., Plapp, F., Golomb, H.M. & Ultman, J.E. (1977) Chromosomal aneuploidy in a patient with hypereosinophilic syndrome: evidence for a malignant disease. American Journal of Medicine, 63, 1010-1014.
3. Bockenstedt, P.L., Santinga, J.T. & Bolling, S.F. (1994) Alpha-interferon treatment for idiopathic hypereosinophilic syndrome. American Journal of Hematology, 45, 248-251.
4. Broustet, A., Bernard, P.L., Dachary, D., David, B., Marit, G., Lacombe, F., Issanchow, A.M. & Reiffers, J. (1986) Acute eosinophilic leukemia with a translocation (10p+;11q). Cancer Genetics and Cytogenetics, 21, 327-333.
5. Bush, F.W., Schmidt, H. & Steinke, B. (1991) Interferon-alpha for the hypereosinophilic syndrome. Annals of Internal Medicine, 114, 338-339.
6. Cabrol, C. (1979) Chromosomal anomaly in eosinophilic leukemia. (Letter). New England Journal of Medicine, 301, 439.
7. Chan, L.C., Kwong, Y.L. & Lie, A.K. (1994) A case of Philadelphia-negative, M-bcr rearranged eosinophilic leukemia with trisomy 8 localized by in situ hybridization. Leukemia, 8, 195-198.
8. Chusid, M.J., Dale, D.C., West, B.C. & Wolff, S.M. (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine, 54, 1-27.
9. Coutant, G., Blétry O., Prin, L., Hauteville D., De Puyfontaine, O., Abgrall, J. & Godeau, P. (1993) Traitement des syndromes hyperéosinophiliques à expression myéloproliférative par l'association hydroxyurée-interféron alpha: a propos de 7 observations. Annales de Medicine Interne, 144, 243-250.
10. Da Silva, M.A.P., Heerema, N., Schwenk, G.R. & Hoffman, R. (1988) Evidence for the clonal nature of hypereosinophilic syndrome. Cancer Genetics and Cytogenetics, 32, 109-115.
11. Dine, G., Najman, A., Brahimi, S., Culioli, B., Abid, A. & Dupoirieux, J. (1992) Syndrome hyperéosinophilique dans une variété myéloproliférative: success d'après 18 mois d'interféron alpha. Press Médicale, 21, 1776.
12. Ellman, L., Hammond, D. & Atkins, L. (1979) Eosinophilia, chloromas and a chromosome abnormality in a patient with a myeloproliferative syndrome. Cancer. 43, 2410-2413.
13. Fauci, A.S., Harley, J.B., Roberts, W.C., Ferrans, W.J., Gralnick, H.R. & Bjornson, B.H. (1982) The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic implications. Annals of Internal Medicine, 97, 78-92.
14. Fischkoff, S.A., Testa, J.R. & Schiffer, C.A. (1988) Acute eosinophilic leukemia with a (10:11) chromosomal translocation. Leukemia, 2, 394-397.
15. Flaum, M.A., Schooley, R.T., Fauci, A.S. & Gralnick, H.R. (1981) A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestions. Blood, 58, 1012-1020.
16. Fruehauf, S., Fiehn, C., Haas, R., Doehner, H. & Hunstein, W. (1993) Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapy. Acta Haematologica, 89, 91-93.
17. Goffman, T.E., Mulvilhill, J.J., Carney, D.N., Triche, T.J. & Whang-Peng, J. (1983) Fatal hypereosinophilia with chromosome 15q-in a patient with multiple primary and familial neoplasms. Cancer Genetics and Cytogenetics, 8, 197-202.
18. Goh, K.O., Ho, F.S.C., Tso, S.C. & Ma, J. (1985) Is hypereosinophilic syndrome a malignant disease? Cancer, 55, 2395-2399.
19. Goldman, J.M., Najfeld, V. & Th'ng, K.H. (1975) Agar culture and chromosome analysis of eosinophilic leukemia. Journal of Clinical Pathology, 28, 956-961.
20. Golomb, H.M. & Ultman, J.E. (1977) Chromosomal aneuploidy in a patient with hypereosinophilic syndrome: evidence for a malignant disease. American Journal of Medicine, 63, 1010-1014.
21. Guitard, A.M., Horschowski, N., Mozziconacci, M.J., Michel, G., George, F., Capodano, A.M. & Perrimond, H. (1994) Hypereosinophilic syndrome in childhood: trisomy 8 and transformation to mixed acute leukaemia. Nouvelle Revue Française d'Hématologie, 35, 555-559.
22. Hansen, P.B., Johnsen, H.E. & Hippe, E. (1993) Hypereosinophilic syndrome treated with α-interferon and granulocyte colony-stimulating factor but complicated by nephrotoxicity. American Journal of Hematology, 43, 66-68.
23. Huang, C.S., Gomez, G.A., Kohno, S.I., Sokal, J.E. & Sandberg, A.A. (1979) Chromosomes and causation of human cancer and leukemia. XXXIV. A case of hypereosinophilic syndrome with unusual cytogenetic findings in a chloroma, terminating in blastic transformation and CNS leukemia. Cancer, 44, 1284-1289.
24. Humphrey, M.J., Hutter, J.J. & Tom, W.W. (1981) Hypereosinophilia in a monosomy 7 myeloproliferative disorder in childhood. American Journal of Hematology, 11, 107-110.
25. Kaneko, Y., Kimpara, H., Kawai, S. & Fijimoto, T. (1983) 8:21 chromosome translocation in eosinophilic leukemia. Cancer Genetics and Cytogenetics, 9, 181-183.
26. Keene, P., Mendelow, B., Pinto, M.R., Bezwoda, W., MacDougall, L., Falkson, G., Ruff, P. & Bernstein, R. (1987) Abnormalities of chromosome 12p13 and malignant proliferation of eosinophils: a nonrandom association. British Journal of Haematology, 67, 25-31.
27. Kobayashi, M., Katayama, T., Ochiai, S., Yoshida, M., Kaito, K., Masuoka, H., Shimada, T., Nishiwaki, K. & Sakai, O. (1993) Interferon-alpha therapy in the myeloproliferative variants of hypereosinophilic syndrome. Rinsko Ketsueki, 34, 367-372.
28. Liesveld, J.L. & Abboud, C.N. (1991) Leukocyte disorders. State of the art: the hypereosinophilic syndromes. Blood Reviews, 5, 29-37.
29. Lönnqvist, B., Gahrton, G., Erikson, P., Friberg, K. & Zech, L. (1979) Isochromosome 17 in a patient with a myeloproliferative disorder terminating in eosinophilic leukaemia. Acta Medica Scandinavica, 206, 321-325.
30. Maeda, K., Van Slyck, E.J. & Van Dyke, D.L. (1985) Multiple myeloma terminating in acute eosinophilic leukemia. Cancer Genetics and Cytogenetics, 16, 81-89.
31. Malbrain, M.L.N.G., Van den Berghe, H., Zachée, P. & Boogaerts, M.A. (1994) Cyclosporin A as treatment for idiopathic hypereosinophilic syndrome. Proceedings of the Belgian Haematological Society, Abstract 26, 65.
32. Meeker, T.C., Hardy, D., Willman, C., Hogan, T. & Abrams, J. (1990) Activation of interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood, 76, 285-289.
33. Michel, G., Thuret, I., Capodano, A.M., Scheiner, C., Guitard, A.M., Mozziconacci, M.J., Fossat, C. & Perrimond, H. (1991) Myelofibrosis in a child suffering from a hypereosinophilic syndrome with trisomy 8: response to corticotherapy. Medical and Pediatric Oncology, 19, 62-65.
34. Mitelman, F., Panani, A. & Brandt, L. (1975) Isochromosome 17 in a case of eosinophilic leukaemia: an abnormality common to eosinophilic and neutrophilic cells. Scandinavian Journal of Haematology, 14, 308-312.
35. Moraillon, I., Bagot, M., Bournerias, I., Prin, L., Weschler, J. & Revuz, J. (1991) Syndrome hyperéosinophilique avec pachydermie précédant un lymphome: traitement par l'interféron alpha. Annales de Dermatologie et de Vénéréologie, 118, 883-885.
36. Murphy, P.T., Fennelly, D.F., Stuart, M. & O'Donnell, J.R. (1990) Alpha-interferon in a case of hypereosinophilic syndrome. British Journal of Haematology, 75, 619-620.
37. Needleman, S.W., Mane, S.M., Gutheil, J.C., Kapil, V., Heyman, M.R. & Testa, J.R. (1990) Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activation. Hematologic Pathology, 4, 149-155.
38. Parreira, L., Tavares de Castro, J., Hibbin, J.A., Marsh, J.C.W., Marcus, R.E., Babupulle, V.B., Spry, C.J.F., Goldman, J.M. & Catovsky, D. (1986) Chromosome and cell culture studies in eosinophilic leukaemia. British Journal of Haematology, 62, 659-669.
39. Parrillo, J.E., Fauci, A.S. & Wolff, S.M. (1978) Therapy of the hypereosinophilic syndrome. Annals of Internal Medicine, 89, 167-172.
40. Prin, L., Plumas, J., Gruart, V., Loiseau, S., Aldebert, D., Ameisen, J.C., Vermersch, A., Fenaux, P., Blétry, O. & Capron, M. (1991) Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in hypereosinophilic syndrome. Blood, 78, 2626-2632.
41. Ribeiro, I., Carvalho, I.R., Fontes, M., Lima, F., Matos, R., Anderson, B.A. & Uva, L.S. (1993) Eosinophilic leukemia with trisomy 8 and double gammopathy. Journal of Clinical Pathology, 46, 672-673.
42. Rowley, J.D. (1983) Human oncogene locations and chromosome aberrations. Nature, 15, 317-326.
43. Schooley, R.T., Flaum, M.A., Gralnick, H.R. & Fauci, A.S. (1981) A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. Blood, 58, 1021-1026.
44. Stockdill, G., Hartley, S.E. & Allan, N.C. (1980) Eosinophilic leukemia in association with a double Philadelphia chromosome. Postgraduate Medical Journal, 56, 268-270.
45. Talpaz, M., Kantarjian, H., Kurzrock, R. & Guttermann, J. (1991) Interferon alpha in the therapy of CML. British Journal of Haematology, 79, 38-41.
46. Talpaz, M., Kantarjian, H.M., McCredie, K.B., Keating, M.J., Trujillo, J. & Gutterman, J. (1987) Clinical investigations of human alpha interferon in chronic myelogenous leukemia. Blood, 69, 1280-1288.
47. Talpaz, M., Kantarjian, H.M., McCredie, K., Trujillo, J.M., Keating, M.J. & Gutterman, J.V. (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. New England Journal of Medicine, 314, 1065-1069.
48. Tono-oka, T., Sato, Y., Matsumoto, T., Ueno, N., Ohkawa, M., Shikano, T. & Takeda, T. (1984) Hypereosinophilic syndrome in acute lymphoblastic leukemia with a chromosome translocation [t(5q;14q]. Medical and Pediatric Oncology, 12, 33-37.
49. Valerius, T., Repp, R., Kalden, J.R. & Platzer, E. (1990) Effects of IFN on human eosinophils in comparison with other cytokines. Journal of Immunology, 145, 2950-2958.
50. Van den Anker-Lugtenburg, P.J. & Van't Veer, M.B. (1991) Alpha-interferon in a case of hypereosinophilic syndrome. British Journal of Haematology, 77, 258.
51. 1-negative eosinophilic leukaemia with trisomy 8: case report and review of cytogenetic studies. Scandinavian Journal of Haematology, 18, 413-420.
52. Wolz, D.E., Granato, J.E., Giles, H.R., Marks, S.M. & Grill, H.P. (1993) A unique chromosomal abnormality in idiopathic hypereosinophilic syndrome presenting with cardiac involvement. American Heart Journal, 126, 246-248.
53. Yoo, T.J., Orman, S.V., Patil, S.R., Dorminey, C., Needleman, S., Rajtora, D., Graves, N., Ackerman, L. & Taylor, W.W. (1984) Evolution to eosinophilic leukemia with a t(5;11) translocation in a patient with idiopathic hypereosinophilic syndrome. Cancer Genetics and Cytogenetics, 11, 389-394.
54. Zabel, P. & Schlaak, M. (1991) Cyclosporin for hypereosinophilic syndrome: case report. Annals of Hematology, 62, 230-231.
55. Zielinski, R.M. & Lawrence, W.D. (1990) Interferon-alpha for the hypereosinophilic syndrome. Annals of Internal Medicine, 113, 716-718.